Sumitomo Mitsui Trust Group
TXG icon

Sumitomo Mitsui Trust Group’s 10x Genomics TXG Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108M Sell
5,110,214
-381,975
-7% -$7.64M 0.07% 258
2025
Q4 		$89.6M Buy
5,492,189
+110,970
+2% +$1.68M 0.05% 316
2025
Q3 		$62.9M Sell
5,381,219
-636,744
-11% -$8.3M 0.04% 402
2025
Q2 		$69.7M Buy
6,017,963
+654,597
+12% +$5.97M 0.04% 370
2025
Q1 		$46.8M Sell
5,363,366
-350,118
-6% -$4.41M 0.03% 458
2024
Q4 		$82M Sell
5,713,484
-659,728
-10% -$10.4M 0.06% 327
2024
Q3 		$144M Buy
6,373,212
+230,145
+4% +$4.76M 0.1% 198
2024
Q2 		$119M Buy
6,143,067
+2,521,289
+70% +$66M 0.09% 218
2024
Q1 		$136M Buy
3,621,778
+1,338,248
+59% +$58.8M 0.09% 224
2023
Q4 		$128M Buy
2,283,530
+565,059
+33% +$24.6M 0.09% 222
2023
Q3 		$70.9M Sell
1,718,471
-47,163
-3% -$2.45M 0.06% 357
2023
Q2 		$98.6M Sell
1,765,634
-255,435
-13% -$13.8M 0.08% 280
2023
Q1 		$113M Sell
2,021,069
-156,919
-7% -$7.33M 0.08% 258
2022
Q4 		$79.4M Sell
2,177,988
-29,270
-1% -$957K 0.06% 358
2022
Q3 		$62.9M Buy
2,207,258
+793,419
+56% +$30.2M 0.05% 413
2022
Q2 		$64M Sell
1,413,839
-204,514
-13% -$10.6M 0.05% 418
2022
Q1 		$123M Buy
1,618,353
+184,168
+13% +$16.1M 0.08% 275
2021
Q4 		$214M Sell
1,434,185
-90,020
-6% -$13.8M 0.13% 175
2021
Q3 		$222M Sell
1,524,205
-215,169
-12% -$36.9M 0.14% 160
2021
Q2 		$341M Buy
1,739,374
+518,185
+42% +$93.8M 0.2% 114
2021
Q1 		$221M Buy
1,221,189
+904,239
+285% +$156M 0.14% 173
2020
Q4 		$44.9M Buy
316,950
+214,682
+210% +$31.2M 0.03% 569
2020
Q3 		$12.8M Sell
102,268
-105,915
-51% -$11.1M 0.01% 739
2020
Q2 		$18.6M Buy
+208,183
New +$16.2M 0.01% 688

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group's TXG Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its 10x Genomics (TXG) stake by 7% in Q1 2026, selling an estimated $7.64M and leaving 5,110,214 shares worth $108M. The position accounts for 0.07% of the portfolio, ranked #258.

Sumitomo Mitsui Trust Group first reported a position in TXG in Q2 2020 and has held it in 24 quarters since. The position peaked at $341M in Q2 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 5,110,214 shares of 10x Genomics worth $108M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 381,975 10x Genomics shares in Q1 2026, an estimated $7.64M.
  • 10x Genomics made up 0.07% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #258 holding.
  • Sumitomo Mitsui Trust Group first reported a position in 10x Genomics in Q2 2020 and has held it in 24 quarters since.
  • Sumitomo Mitsui Trust Group's 10x Genomics position peaked at $341M in Q2 2021.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.